High throughput screening in academia - Drug discovery initiatives at the University of Kansas

Drug Discovery World

Volumn 9, Issue 4, 2008, Pages 59-76

  McDonald, Peter R ^a   Roy, Anuradha ^b   Tylor, Byron ^c   Price, Ashleigh ^d   Sittampalam, Sitta ^e   Weir, Scott ^e   Chaguturu, Rathnam ^f  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b PTC Therepeutics Inc

^c Amgens Department of HTS and Molecular Pharmacology

^d IBT Laboratories

^e Office of Therapeutics Discovery and Development

^f KU HTSL ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; MEMBRANE PROTEIN; PEPTIDE; PHOSPHOTRANSFERASE; RECOMBINANT PROTEIN;

ANALYZER; ARTICLE; BINDING AFFINITY; BIOASSAY; BIOTECHNOLOGY; COMPUTER PROGRAM; COST; DRUG APPROVAL; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; DRUG SCREENING; HIGH THROUGHPUT SCREENING; IMMUNOGENICITY; INVESTMENT; MEDICAL RESEARCH; PATENT; QUALITY CONTROL; SYSTEMS BIOLOGY;

EID: 55349142120     PISSN: 14694344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Hughes, B. (2008) 2007 FDA Drug Approvals: A Year of Flux. Nat Rev. Drug Disc. 7 (2); 107-109.
2. Austin, CP et al. (2004) NIH Molecular Libraries Initiative. Science 306 (5699), 1138-1139.
3. Lazo,JS et al. (2007) Building a pharmacological lexicon: small molecule discovery in academia. Mol Pharmocol 72 (1), 1-7.
4. Kaiser, J. (2008) Molecular biology. Industrial-style screening meets academic biology. Science 321 (5890), 764-766.
5. Camp, D et al. (2007) Progress toward establishing an open access molecular screening capability in the Australasian region. ACS Chem Biol 2 (12), 764-767.